Abstract
Background
Obesity is associated with a twofold risk of gastroesophageal reflux disease (GERD) and thrice the risk of Barrett’s esophagus (BE). Roux-en-Y gastric bypass (RYGB) leads to weight loss and improvement of GERD in population with obesity, but its effect on BE is less clear.
Methods
Bibliographic databases were searched systematically for relevant articles till January 31, 2019. Studies evaluating the effect of RYGB on BE with preoperative and postoperative endoscopy and biopsy were included. Study quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS) tool. Meta-analysis was conducted using Mantel-Haenszel, random effects model and presented as risk difference (RD) or odds ratio (OR) with 95% confidence intervals.
Results
Eight studies with 10,779 patients undergoing RYGB reported on 117 patients with BE with follow-up of > 1 year. Significant regression of BE after RYGB was observed (RD − 0.56.95% c.i. − 0.69 to − 0.43; P < 0.001). Subgroup analysis showed regression of both short-segment BE [ssBE] (RD − 0.51.95% c.i. − 0.68 to − 0.33; P < 0.001) and long-segment BE [lsBE] (RD − 0.46.95% c.i. − 0.71 to − 0.21; P < 0.001). RYGB also caused improvement in GERD in patients of BE (RD − 0.93, 95% c.i. − 1.04 to − 0.81; P < 0.001). RYGB was strongly associated with regression of BE compared with progression (OR 31.2.95% c.i. 11.37 to 85.63; P < 0.001).
Conclusions
RYGB leads to significant improvement of BE at > 1 year after surgery in terms of regression and resolution of the associated GERD. Both ssBE and lsBE improve after RYGB significantly.
Similar content being viewed by others
References
Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.
Moersch RN, Ellis Jr FH, Mc DJ. Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet. 1959;108:476–84.
Stein HJ, Siewart JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8(3):276–88.
Hamade N, Vennelaganti S, Parasa S, et al. Lower annual rate of progression of short-segment vs long-segment Barrett’s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2019;17(5):864-868.
Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am. 2015;44(2):203–31.
Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett’s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61(2):226–31.
Braghetto I, Csendes A. Patients having bariatric surgery: surgical options in morbidly obese patients with Barrett’s esophagus. Obes Surg. 2016;26:1622–6.
Nandurkar S, Locke 3rd GR, Fett S, et al. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004;20(5):497–505.
Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:872–8.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.
Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 1998;93:1028–32.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.
Zhang N, Maffei A, Cerabona T, et al. Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc. 2013;27(4):1273–80.
Park C, Portenier D. Reflux, Barrett’s esophagus & bariatric surgery: working towards a clinical pathway for the management of a pre-cancerous condition in bariatric surgery patients. Surg Obes Relat Dis. 2015;11(6):S118.
Cobey F, Oelschlager B. Complete regression of Barrett’s esophagus after Roux-en-Y gastric bypass. Obes Surg. 2005;15:710–2.
O'Connor D, Green S, Higgins JPT. Defining the review question and developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0: The Cochrane Collaboration; 2013. Available at - https://handbook-5-1.cochrane.org/chapter_5/5_defining_the_review_question_and_developing_criteria_for.htm. Accessed 27 Feb 2019.
Centre for reviews and dissemination. Systematic reviews: CRD's guidance for undertaking reviews in healthcare. York: University of York; 2009. Available at - https://www.york.ac.uk/crd/guidance/. Accessed 27 Feb 2019.
Moher D, Liberali A, Telzlaff J, et al. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. BMJ. 2009;339:b2535.
Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.
Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.
Lewis S, Clarke M. Forest plots: trying to see the wood and the trees. BMJ. 2001;322(7300):1479–80.
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Higgins JPT, Thompson SG, Deeks JJ. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.
Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4(1):1–4.
Ben-Meir A, Sonpal I, Salomone MG. Roux-en-Y gastric bypass (RYGB) improves Barrett’s esophagus. Surg Obes Relat Dis. 2010;6(3):S48–9.
Braghetto I, Korn O, Csendes A, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22(5):764–72.
Pereira N, Csendes A, Smok G, et al. Effects of gastric bypass for morbid obesity on Barrett esophagus. Rev Chilena Cirugía. 2012;64(2):155–60.
Dova G, Caro LE, Brasesco O, et al. Effects of gastric bypass in obese patients with Barrett’s esophagus. Gastrointest Endosc. 2016;83(5):AB551.
Gorodner V, Buxhoeveden R, Clemente G, et al. Barrett’s esophagus after roux-en-Y gastric bypass: does regression occur? Surg Endosc. 2017;31(4):1849–54.
Andrew B, Alley JB, Aquiar CE, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32(2):930–6.
Nguyen DM, El-Serag HB, Henderson L, et al. Medication usage and the risk of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2009;7:1299–304.
Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.
Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2011;106:1899–908.
Mino-Kenudson M, Brugge WR, Puricelli WP, et al. Management of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol. 2005;29:680–6.
Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut. 2010;59:1169–77.
Simonka Z, Paszt A, Abraham S, et al. The effects of laparoscopic Nissen fundoplication on Barrett’s esophagus: long-term results. Scand J Gastroenterol. 2012;47:13–21.
Hofstetter WL, Peters JH, DeMeester TR, et al. Long-term outcome of antireflux surgery in patients with Barrett’s esophagus. Ann Surg. 2001;234:532–8.
Guruski RR, Peters JH, Hagen JA, et al. Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg. 2003;196(5):706–12.
Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.
Zehetner J, DeMeester SR, Ayazi S, et al. Long-term follow-up after anti-reflux surgery in patients with Barrett’s esophagus. J Gastrointest Surg. 2010;14:1483–91.
Kellogg TA, Andrade R, Maddaus M, et al. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):52–7.
Morgenthal CB, Lin E, Shane MD, et al. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc. 2007;21(11):1978–84.
Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc. 2001;15:986–9.
Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19:200–21.
Anderson MA, Gan SI, Fanelli RD, et al. Role of endoscopy in the bariatric surgery patient. Gastrointest Endosc. 2008;68:1–10.
Abd EME, Alfalah H, Asker WA, et al. Place of upper endoscopy before and after bariatric surgery: a multicenter experience with 3219 patients. World J Gastrointest Endosc. 2016;8(10):409–17.
Gomez V, Bhalla R, Heckman MG, et al. Routine screening endoscopy before bariatric surgery: is it necessary? Bariatr Surg Pract Patient Care. 2014;9(4):143–9.
Acknowledgments
M.T.A is grateful to the research committee members of Obesity Service, Luton and Dunstable University Hospital, UK, for the support he received to carry out this research, including acceptance of the study protocol and analysis plan.
Author information
Authors and Affiliations
Contributions
K.M suggested the importance of carrying out this research. M.T.A and K.M. conducted the literature search and were involved in the selection of studies. M.T.A, K.M, F.R, and V.J were involved in extraction of data. M.T.A, O.A, and A.M were involved in data analysis and interpretation. M.T.A, P.J, and D.W performed the assessment of risk of bias in the included studies. All authors contributed to the write-up, corrections, validation, and final approval of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
The study protocol was approved by the research committee of Obesity Service, Luton and Dunstable University Hospital, including research methodology and analysis plan detailed in the manuscript.
Competing Interests
The authors declare that they have no competing interests in relation to this manuscript.
Consent to Participate
We declare that consent to participate is not applicable to this study.
Consent to Publish
We declare that consent to publish is not applicable to this study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Suggested text for special media/twitter: Roux-en-Y Gastric Bypass leads to regression of Barrett’s Esophagus in more than 50% patients.
Rights and permissions
About this article
Cite this article
Adil, M.T., Al-taan, O., Rashid, F. et al. A Systematic Review and Meta-Analysis of the Effect of Roux-en-Y Gastric Bypass on Barrett’s Esophagus. OBES SURG 29, 3712–3721 (2019). https://doi.org/10.1007/s11695-019-04083-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-019-04083-0